Patients with refractory cardiogenic shock can benefit from veno-arterial extracorporeal membrane oxygenation (VA-ECMO). The use of levosimendan in VA-ECMO patients may facilitate weaning and enhance survival.
Beneficial effects of levosimendan to wean patients from VA-ECMO: a systematic review and meta-analysis / Bertini, Pietro; Paternoster, Gianluca; Landoni, Giovanni; Falcone, Marco; Nocci, Matteo; Costanzo, Diego; Brizzi, Giulia; Romani, Matteo; Esposito, Andrea; Guarracino, Fabio. - In: MINERVA CARDIOLOGY AND ANGIOLOGY. - ISSN 2724-5772. - 71:5(2023), pp. 564-574. [10.23736/S2724-5683.22.06054-9]
Beneficial effects of levosimendan to wean patients from VA-ECMO: a systematic review and meta-analysis
Landoni, Giovanni;
2023-01-01
Abstract
Patients with refractory cardiogenic shock can benefit from veno-arterial extracorporeal membrane oxygenation (VA-ECMO). The use of levosimendan in VA-ECMO patients may facilitate weaning and enhance survival.File in questo prodotto:
Non ci sono file associati a questo prodotto.
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
